NCT06795399View on ClinicalTrials.gov

A Proof-of-concept Trial for OPC 131461 in Patients Hospitalized for Worsening Heart Failure

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

264

Participants

Timeline

Start Date

April 30, 2025

Primary Completion Date

January 31, 2027

Study Completion Date

January 31, 2027

Conditions
Heart Failure
Interventions
DRUG

OPC-131461

OPC-131461 will be administered as oral tablets.

DRUG

Placebo

OPC-131461 matched placebo will be administered as oral tablets.

All Listed Sponsors
lead

Otsuka Pharmaceutical Development & Commercialization, Inc.

INDUSTRY